标题
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-03-15
DOI
10.3389/fcimb.2022.823684
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mobile Carbapenemase Genes in Pseudomonas aeruginosa
- (2021) Eun-Jeong Yoon et al. Frontiers in Microbiology
- Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model
- (2021) Mao Hagihara et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
- (2021) Shu-Chen Kuo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
- (2021) Hsin-Yu Chen et al. Frontiers in Cellular and Infection Microbiology
- Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018
- (2021) Shio-Shin Jean et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
- (2021) Po-Yu Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Global Distribution Patterns of Carbapenemase-Encoding Bacteria in a New Light: Clues on a Role for Ethnicity
- (2021) Claudio Neidhöfer et al. Frontiers in Cellular and Infection Microbiology
- Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
- (2021) Adam B. Shapiro et al. Frontiers in Microbiology
- Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China
- (2021) Kai Yang et al. Journal of Global Antimicrobial Resistance
- Susceptibility to Imipenem/Relebactam of Pseudomonas aeruginosa and Acinetobacter baumannii Isolates from Chinese Intra-Abdominal, Respiratory and Urinary Tract Infections: SMART 2015 to 2018
- (2021) Hui Zhang et al. Infection and Drug Resistance
- Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan, 2020
- (2021) Shio-Shin Jean et al. Expert Review of Anti-Infective Therapy
- Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review
- (2021) Mihret Tilahun et al. Infection and Drug Resistance
- Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections
- (2020) Renee Ackley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019
- (2020) Lara Tavoschi et al. Eurosurveillance
- In vitro efficacy of Imipenem-Relebactam and Cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae
- (2020) L. Tselepis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae
- (2020) Chi-Chung Chen et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Oral colonisation by antimicrobial-resistant Gram-negative bacteria among long-term care facility residents: prevalence, risk factors, and molecular epidemiology
- (2020) Mi Nguyen-Tra Le et al. Antimicrobial Resistance and Infection Control
- Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia
- (2020) Shio-Shin Jean et al. Journal of Clinical Medicine
- Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry
- (2020) Adriana Jimenez et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Structural basis of reduced susceptibility to ceftazidime–avibactam and cefiderocol in Enterobacter cloacae due to AmpC R2 loop deletion
- (2020) Akito Kawai et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments
- (2020) Anna Olsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multispecies Outbreak of Verona Integron-Encoded Metallo-ß-Lactamase-Producing Multidrugresistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2
- (2020) Tom J B de Man et al. CLINICAL INFECTIOUS DISEASES
- Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination
- (2020) Andrea Novelli et al. Expert Review of Anti-Infective Therapy
- In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China
- (2020) Xiaojuan Wang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rapid identification of bloodstream bacterial and fungal pathogens and their antibiotic resistance determinants from positively flagged blood cultures using the BioFire FilmArray blood culture identification panel
- (2020) Chun-Min Kang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Antimicrobial resistance comparison of Klebsiella pneumoniae pathogens isolated from intra-abdominal and urinary tract infections in different organs, hospital departments and regions of China between 2014 and 2017
- (2020) Hui Zhang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Molecular epidemiology and resistance patterns of blaOXA-48 Klebsiella pneumoniae and Escherichia coli: A nationwide multicenter study in Taiwan
- (2020) Ching-Hsun Wang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems
- (2020) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital
- (2020) Zhongliang Duan et al. BMC MICROBIOLOGY
- An evaluation of meropenem + vaborbactam for the treatment of nosocomial pneumonia
- (2020) Lauren M. Groft et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Clinical and Microbiological Characteristics of Community-Onset Carbapenem-Resistant Enterobacteriaceae Isolates
- (2020) Hangbin Hu et al. Infection and Drug Resistance
- Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
- (2020) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High mortality by nosocomial infections caused by carbapenem-resistant P. aeruginosa in a referral hospital in Brazil: facing the perfect storm
- (2020) Jane Eire Urzedo et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of blaOXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait
- (2020) Amani H. Al Fadhli et al. PLoS One
- In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa: Results from a Multicenter Study in China, 2017
- (2019) Dandan Yin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The new perspective of old antibiotic: In vitro antibacterial activity of TMP-SMZ against Klebsiella pneumoniae
- (2019) Jiahui Li et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Carbapenem-resistant Acinetobacterbaumannii: in pursuitof an effective treatment
- (2019) Evangelia-Theophano Piperaki et al. CLINICAL MICROBIOLOGY AND INFECTION
- The SHIELD Orange County Project –Multi Drug-Resistant Organism (MDRO) Prevalence in 21 Nursing Homes and Long Term Acute Care Facilities in Southern California
- (2019) James A McKinnell et al. CLINICAL INFECTIOUS DISEASES
- Beyond piperacillin-tazobactam: cefepime and AAI101 as a potent β-lactam-β-lactamase inhibitor combination
- (2019) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of cefepime-enmetazobactam against Gram-negative isolates collected from United States and European hospitals during 2014-2015
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
- (2019) Shio-Shin Jean et al. DRUGS
- High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease
- (2019) Dien M. Tran et al. JOURNAL OF INFECTION
- Imipenemase-producing carbapenem-resistant Enterobacteriaceae transmission in a long-term-care facility during a community-wide multidrug resistant organism outbreak—North Carolina, 2017
- (2019) Heather Dubendris et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC
- (2019) Melissa D. Barnes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of outer membrane permeability, efflux mechanism, and carbapenemases in carbapenem-nonsusceptible Pseudomonas aeruginosa from Dubai hospitals: Results of the first cross-sectional survey
- (2019) Carole Ayoub Moubareck et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition
- (2019) Thanyaluck Siriyong et al. Scientific Reports
- Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
- (2019) Basem M. Alraddadi et al. BMC INFECTIOUS DISEASES
- Bronchoscope-Related “Superbug” Infections
- (2019) Atul C. Mehta et al. CHEST
- Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study
- (2019) Melissa G McCracken et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae
- (2019) Maria Loose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
- (2019) Patrice Nordmann et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria
- (2019) Yoshinori Yamano CLINICAL INFECTIOUS DISEASES
- Meropenem–nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model
- (2019) Tomefa E. Asempa et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
- (2019) Lei Wang et al. Frontiers in Microbiology
- Heteroresistance to colistin in oxacillinases-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran
- (2019) Fereshteh Ezadi et al. Journal of Global Antimicrobial Resistance
- Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae
- (2019) Kayoko Hayakawa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Resistance to Ceftazidime-Avibactam and Underlying Mechanisms
- (2019) Yuhang Wang et al. Journal of Global Antimicrobial Resistance
- Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany
- (2019) Elena Schäfer et al. Antimicrobial Resistance and Infection Control
- Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group
- (2018) Hideharu Hagiya et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria
- (2018) Elisabetta Nucleo et al. Antimicrobial Resistance and Infection Control
- Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis
- (2018) Gowri Raman et al. Antimicrobial Resistance and Infection Control
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015–17)
- (2018) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
- (2018) Pranita D. Tamma et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis
- (2018) Eliseth Costa Oliveira de Matos et al. Revista da Sociedade Brasileira de Medicina Tropical
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
- (2018) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
- (2018) Shun-Chung Hsueh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae
- (2018) Shazad Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
- (2018) Shio-Shin Jean et al. Frontiers in Microbiology
- Prevalence of different carbapenemase genes among carbapenem-resistant Acinetobacter baumannii blood isolates in Taiwan
- (2018) Teng-Ho Wang et al. Antimicrobial Resistance and Infection Control
- The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
- (2018) Effat Davoudi-Monfared et al. Infection and Drug Resistance
- In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
- (2018) Shio-Shin Jean et al. Infection and Drug Resistance
- Appropriate treatment for bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae and Escherichia coli: A nationwide multicenter study in Taiwan
- (2018) Yi-Tsung Lin et al. Open Forum Infectious Diseases
- Epidemiology of Carbapenem-Resistant Enterobacteriaceae at a Long-term Acute Care Hospital
- (2018) Teena Chopra et al. Open Forum Infectious Diseases
- Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients
- (2017) L. Lapointe-Shaw et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Healthcare Antibiotic Resistance Prevalence – DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia
- (2017) Jacqueline Reuben et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Carbapenem-resistant Enterobacteriaceae in the community: a scoping review
- (2017) Ana M. Kelly et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2017) Kirati Kengkla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rapid Detection of Carbapenemases in Enterobacteriaceae: Evaluation of the Resist-3 O.K.N. (OXA-48, KPC, NDM) Lateral Flow Multiplexed Assay
- (2017) David W. Wareham et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan
- (2017) Chun-Ming Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Update on fosfomycin-modified genes in Enterobacteriaceae
- (2017) Tsung-Ying Yang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting
- (2017) Abdul Rahman Zaidah et al. Antimicrobial Resistance and Infection Control
- Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China
- (2017) Yan Yang et al. Frontiers of Medicine
- Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
- (2017) Rong Zhang et al. EBioMedicine
- Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study
- (2017) Thomas Howe McConville et al. PLoS One
- Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors
- (2016) Cheston B. Cunha et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City
- (2016) Nishant Prasad et al. AMERICAN JOURNAL OF INFECTION CONTROL
- A prolonged outbreak of KPC-3-producing Enterobacter cloacae and Klebsiella pneumoniae driven by multiple mechanisms of resistance transmission at a large academic burn center
- (2016) Hajime Kanamori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan
- (2016) Cheng-Yen Kao et al. BMC MICROBIOLOGY
- Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-ResistantEnterobacteriaceaeBacteremia
- (2016) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.
- (2016) Ryan K. Shields et al. CLINICAL INFECTIOUS DISEASES
- Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
- (2016) Tamar F. Barlam et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-Resistant Bacteria in the Community
- (2016) David van Duin et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa
- (2016) Martin Vestergaard et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Genomic islands 1 and 2 carry multiple antibiotic resistance genes in Pseudomonas aeruginosa ST235, ST253, ST111 and ST175 and are globally dispersed
- (2016) Piklu Roy Chowdhury et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
- (2016) Zaira R. Palacios-Baena et al. JOURNAL OF INFECTION
- Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin
- (2016) Hung-Jen Tang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
- (2016) Shio-Shin Jean et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
- (2016) Belén Gutiérrez-Gutiérrez et al. MAYO CLINIC PROCEEDINGS
- Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?
- (2016) Sandra S. Richter et al. Virulence
- Multilocus Sequence Typing Analysis of Carbapenem-Resistant Acinetobacter baumannii in a Chinese Burns Institute
- (2016) Guangtao Huang et al. Frontiers in Microbiology
- Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
- (2016) Sami Abdellatif et al. Annals of Intensive Care
- Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009)
- (2016) David P. Kateete et al. SpringerPlus
- Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates
- (2016) Hung-Jen Tang et al. PLoS One
- In VitroActivity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
- (2015) Douglas J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa – an update
- (2015) Michelle Lowings et al. BMC INFECTIOUS DISEASES
- Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
- (2015) Aristine Cheng et al. CRITICAL CARE MEDICINE
- Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections
- (2015) Warren Lowman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)
- (2015) KE Goodman et al. Expert Review of Anti-Infective Therapy
- Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options
- (2015) Shio-Shin Jean et al. Future Microbiology
- The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents
- (2015) John P Mills et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Prevalence of and Risk Factors for Multidrug-Resistant Acinetobacter baumannii Colonization Among High-Risk Nursing Home Residents
- (2015) Lona Mody et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital
- (2015) B. Semin-Pelletier et al. JOURNAL OF HOSPITAL INFECTION
- Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections
- (2015) Diana P. Pires et al. JOURNAL OF VIROLOGY
- Pediatric Carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a High-prevalence Region in the United States
- (2015) Pia S. Pannaraj et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Antimicrobial resistance profiles and oxacillinase genes in carbapenem-resistant Acinetobacter baumannii isolated from hospitalized patients in Santa Catarina, Brazil
- (2015) Giselle Dall Cortivo et al. Revista da Sociedade Brasileira de Medicina Tropical
- Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital
- (2015) Yaowen Chang et al. Frontiers in Microbiology
- Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital
- (2015) Faten M. Elabd et al. Journal of Infection and Public Health
- Pulmonary and Systemic Pharmacokinetics of Inhaled and Intravenous Colistin Methanesulfonate in Cystic Fibrosis Patients: Targeting Advantage of Inhalational Administration
- (2014) S. W. S. Yapa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa
- (2014) A. F. Voor in 't holt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An outbreak of extremely drug-resistant Pseudomonas aeruginosain a tertiary care pediatric hospital in Italy
- (2014) Marta Ciofi degli Atti et al. BMC INFECTIOUS DISEASES
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review
- (2014) P. Poulikakos et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Spread of Klebsiella pneumoniae carbapenemase-2-producing Klebsiella pneumoniae clones in Asia
- (2014) Shio-Shin Jean et al. Future Microbiology
- Risk Factors for Colonization due to Carbapenem-Resistant Enterobacteriaceae among Patients: Exposed to Long-Term Acute Care and Acute Care Facilities
- (2014) Ashish Bhargava et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Statewide Surveillance of Carbapenem-Resistant Enterobacteriaceae in Michigan
- (2014) Brenda M. Brennan et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Epidemiology of Metalloenzyme-ProducingPseudomonas aeruginosain a Tertiary Hospital in Greece
- (2014) S. Zappas et al. JOURNAL OF CHEMOTHERAPY
- CarbAcineto NP Test for Rapid Detection of Carbapenemase-Producing Acinetobacter spp.
- (2014) L. Dortet et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Code blue:Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity
- (2014) A.M. Richards et al. Molecular Oral Microbiology
- Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
- (2014) Young Kyung Yoon et al. PLoS One
- Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
- (2013) Milena McLaughlin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae
- (2013) Michael Y. Lin et al. CLINICAL INFECTIOUS DISEASES
- KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality
- (2013) Matthaios Papadimitriou-Olivgeris et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control analysis
- (2013) C. Lübbert et al. INFECTION
- Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009
- (2013) Shio-Shin Jean et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
- (2013) Mark Bounthavong et al. Infection and Drug Resistance
- The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
- (2012) Meredith G. Jernigan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia
- (2012) Laura Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
- (2012) A. Capone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Outbreak of Carbapenem-Resistant Enterobacteriaceae at a Long-Term Acute Care Hospital: Sustained Reductions in Transmission through Active Surveillance and Targeted Interventions
- (2012) Amit S. Chitnis et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Comparative Evaluation of a Prototype Chromogenic Medium (ChromID CARBA) for Detecting Carbapenemase-Producing Enterobacteriaceae in Surveillance Rectal Swabs
- (2012) Georgia Vrioni et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of Four Chromogenic Culture Media for Carbapenemase-Producing Enterobacteriaceae
- (2012) K. M. Wilkinson et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit - a systematic review of risk factors and environmental sources
- (2012) J. M. C. Jefferies et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients
- (2012) Jayant S. Kalpoe et al. LIVER TRANSPLANTATION
- Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients
- (2012) Ryan K. Shields et al. PLoS One
- Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
- (2011) Abraham Borer et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
- (2011) Catharine C. Bulik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
- (2011) N. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
- (2011) Debby Ben-David et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
- (2011) Marie Kempf et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes
- (2011) Y.-C. Lee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination Antibiotic Therapy for Empiric and Definitive Treatment of Gram-Negative Infections: Insights from the Society of Infectious Diseases Pharmacists
- (2011) Natalie Boyd et al. PHARMACOTHERAPY
- Contribution of a Plasmid-Borne blaOXA-58 Gene with Its Hybrid Promoter Provided by IS1006 and an ISAba3-Like Element to -Lactam Resistance in Acinetobacter Genomic Species 13TU
- (2010) T.-L. Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug‐ResistantAcinetobacter baumannii:An Emerging Pathogen among Older Adults in Community Hospitals and Nursing Homes
- (2010) D. M. Sengstock et al. CLINICAL INFECTIOUS DISEASES
- Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals
- (2010) Jie Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli
- (2010) Sho Takahata et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases
- (2010) Constantinos C. Papagiannitsis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii
- (2010) Wang-Huei Sheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Sequence types of Portuguese carbapenem-resistant Acinetobacter baumannii isolates collected over 10 years
- (2010) G. J. Da Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- Impact of multidrug-resistantPseudomonas aeruginosainfection on patient outcomes
- (2010) Elizabeth B Hirsch et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases
- (2009) P. Giakkoupi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia
- (2009) Chia-Cheng Tseng et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
- (2009) Abraham Borer et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- A Stenotrophomonas maltophilia Multilocus Sequence Typing Scheme for Inferring Population Structure
- (2009) S. Kaiser et al. JOURNAL OF BACTERIOLOGY
- The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care Facilities
- (2009) E. O'Fallon et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation